Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2026-04-07 @ 4:15 PM
Study NCT ID:
NCT06984094
Status:
RECRUITING
Last Update Posted:
2025-08-08
First Post:
2025-05-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults
Sponsor:
Clover Biopharmaceuticals AUS Pty
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-18
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-14
First Submit QC Date:
None
Study First Post Date:
2025-05-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-05
Last Update Post Date:
2025-08-08
Last Update Post Date Type:
ACTUAL